ASIT Biotech S.A. | Ownership
Companies that own ASIT Biotech S.A.
BNP Paribas Asset Management Belgium SA
122,854
0.72%
0
0%
07/31/2018
HSBC Global Asset Management (France) SA
68,592
0.4%
0
0%
12/29/2017
FundQuest Advisor
57,146
0.33%
0
0.05%
07/31/2018
LCL Asset Management AB
21,250
0.12%
0
0.16%
06/30/2017
OFI Asset Management SA
10,000
0.06%
1,500
0%
12/29/2017
Friedland Gestion SAS
1,750
0.01%
0
0.05%
09/29/2017
| Address |
Avenue Ariane 5
Woluwe-Saint-Lambert BU 1200
Belgium
|
|
Employees
|
- |
| Website |
http://www.asitbiotech.com |
| Updated |
07/08/2019 |
| ASIT BioTech SA operates as clinical stage biopharmaceutical company. It focuses on the development and future commercialization of immunotherapy products for the treatment of allergies, based on its ASIT technology platform. The company was founded by Thierry Legon in May 1997 and is headquartered in Brussels, Belgium. |
